Medigen Vaccine Biologics Corporation (TPEX:6547)
Taiwan
· Delayed Price · Currency is TWD 48.80
+0.45 (0.93%)
Apr 24, 2025, 1:30 PM CST
Medigen Vaccine Biologics Market Cap
Medigen Vaccine Biologics has a market cap or net worth of 16.04 billion as of April 24, 2025. Its market cap has decreased by -8.75% in one year.
Market Cap
16.04B
Enterprise Value
14.47B
Revenue
605.64M
Ranking
n/a
PE Ratio
n/a
Stock Price
48.80
Market Cap Chart
Since August 6, 2015, Medigen Vaccine Biologics's market cap has increased from 2.83B to 16.04B, an increase of 465.89%. That is a compound annual growth rate of 19.51%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 165.85B |
| Caliway Biopharmaceuticals | 94.31B |
| Bora Pharmaceuticals Co., LTD. | 69.01B |
| Lotus Pharmaceutical | 56.52B |
| Oneness Biotech | 29.30B |
| Polaris Group | 29.08B |
| Lumosa Therapeutics | 26.77B |
| Pegavision | 25.55B |